MONDTI: Molecular characterisation platform for identifying actionable mutations in advanced or metastatic cancers. (December 2016) - Kieler, M.; Warzecha, A.; Müllauer, L.; Waneck, F.; Mader, R.; Wrba, F.; Schmidinger, M.; Scheithauer, W.; Marosi, C.; Raderer, M.; Hejna, M.; Füreder, T.; et al.